Orgenesis Inc. (ORGS) Social Stream
Orgenesis Inc (ORGS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ORGS.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued June 18, 2021
The Trend in the Analyst Price Target
Over the past 135 days, ORGS's average price target has gone down $0.
ORGS reports an average of 76.29% for its upside potential over the past 170 days.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ORGS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ORGS as an investment opportunity.
- In terms of how Orgenesis Inc fares relative to all US stocks, note that its number of analysts covering the stock is higher than nearly none of that group.
- To contextualize these metrics, consider that out of all US stocks, Orgenesis Inc's variance in analysts' estimates is lower than just about 100% of them.
- In the context of Healthcare stocks, Orgenesis Inc's average analyst price target is higher than 13.43% of them.
- In the context of stocks in the micro market cap category, Orgenesis Inc's upside potential (average analyst target price relative to current price) is higher than 40.75% of them.
Is ORGS a Buy, Hold or Sell? See the POWR Ratings now!